Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.23.1
Equity (Tables)
3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
Schedule of summary of stock option activity
(in thousands, except for per-share amounts)   Number of Shares     Weighted
Average
Exercise
Price ($)
    Weighted
Average
Remaining
Contractual
Term
(in years)
    Aggregate
Intrinsic
Value
 
Outstanding, January 1, 2023     3,396     $ 8.00       8.85     $ 15,204  
Granted     11       10.89                  
Exercised     (1 )     7.00                  
Cancelled     (82 )     5.76                  
Outstanding, March 31, 2023     3,324       8.07       8.50       11,114  
                                 
Exercisable, March 31, 2023     975       13.66       7.21       2,304  

 

Schedule of summary of restricted stock unit activity
(in thousands, except for per-share amount)   RSUs     Weighted
Average
Grant date Fair Value
Per Share ($)
 
Outstanding, January 1, 2023     325       5.96  
Granted    
-
     
-
 
Vested    
-
     
-
 
Outstanding, March 31, 2023     325       5.96  

 

Schedule of stock option activity
(in thousands, except for per-share amounts)   Number of Shares     Weighted
Average
Exercise
Price ($)
    Weighted
Average
Remaining
Contractual
Term
(in years)
    Aggregate
Intrinsic
Value
 
Outstanding, January 1, 2023     1,443     $ 16.58       1.33     $ 5  
Granted    
-
     
-
                 
Expired    
-
     
-
                 
Outstanding, March 31, 2023     1,443     $ 16.58       1.08     $ 2  
                                 
Exercisable, March 31, 2023     1,440     $ 15.94       1.08     $ 2